Abdi Ibrahim Purchased OM Pharma’s Shares
Highlights: Turkish pharma giant Abdi Ibrahim acquired a 28.5% stake for US$530 million in Swiss biotech OM Pharma to increase access to the MENA market, OIC countries, and the Americas. Some drugs are to be produced in Turkey.
Link to Original Article